LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

LLY

995.84

-1.3%↓

JNJ

201.6

-0.09%↓

ABBV

222.95

-1.45%↓

UNH

323.16

-2.22%↓

AZN

91.2

+1.13%↑

Home・Akcijų sąrašas・Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

38.75 -2.69

Pirkti Parduoti

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

38.45

Max

39.57

Pagrindiniai rodikliai
By Trading Economics
Pajamos	11M 51M
Pardavimai	39M 239M
P/E Sektoriaus vid.	11.202 80.03
Pelnas, tenkantis vienai akcijai	1.08
Pelno marža	21.242
Darbuotojai	268
EBITDA	14M 73M

Rekomendacijos
By TipRanks
Rekomendacijos	Stiprus pirkimas
12 mėnesių prognozė	+15.49% upside

Rinkos statistika
By TradingEconomics
Rinkos kapitalizacija	358M 2B
Ankstesnė atidarymo kaina	41.44
Ankstesnė uždarymo kaina	38.75

Naujienos nuotaikos

By Acuity

50%

166 / 374 reitingas Healthcare

Techninis įvertinimas

By Trading Central

Pasitikėjimas

Weak Bullish Evidence

29.8 / N/A Palaikymas ir pasipriešinimas

Harmony Biosciences Holdings Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-12-08 23:48; UTC

Pagrindinės rinkos jėgos

Shares of Sezzle and Vital Farms Rise on S&P SmallCap 600 Inclusion

2025-12-08 23:44; UTC

Rinkos pokalbiai

Perky Australian Dollar Looks to Extend Gains -- Market Talk

2025-12-08 23:42; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Uncertainty Over Econ, Earnings -- Market Talk

2025-12-08 23:13; UTC

Rinkos pokalbiai

Global Forex and Fixed Income Roundup: Market Talk

2025-12-08 23:13; UTC

Rinkos pokalbiai

Australian Inflation Expectations Highest Since Late 2023 -- Market Talk

2025-12-08 23:09; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Made a Hostile Bid for Warner After Netflix Deal. What Happens Next? -- WSJ

2025-12-08 22:46; UTC

Rinkos pokalbiai

Rio Tinto Building Low-Cost Lithium Business in Difficult Market -- Market Talk

2025-12-08 22:01; UTC

Rinkos pokalbiai

Miners Poised to Do Well in 2026 -- Market Talk

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Borr Includes Sale of Noble Tom Prosser, Noble Mick O'Brien, Noble Regina Allen, Noble Resilient, Noble Resolute, Closing Expected in Early 2026 >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Borr Comprises $210M in Cash and $150M in Seller Notes >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: Agreement With Ocean Oilfield Drilling Anticipates the Sale of the Noble Resolve, Closing Is Expected in 2Q 2026, Upon Conclusion of Noble Resolve's Current Contract >NE

2025-12-08 22:00; UTC

Įsigijimai, susijungimai, perėmimai

Noble: To Sell Five Rigs to Borr Drilling Limited for $360M and One Rig to Ocean Oilfield Drilling for $64M in Cash >NE

2025-12-08 21:51; UTC

Rinkos pokalbiai

US-Canada Rate Spreads Narrow Sharply After Record Gap -- Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Tech, Media & Telecom Roundup: Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Auto & Transport Roundup: Market Talk

2025-12-08 21:50; UTC

Rinkos pokalbiai

Basic Materials Roundup: Market Talk

2025-12-08 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Boeing Buys Company Responsible for Door Blowout. The Stock Rises. -- Barrons.com

2025-12-08 21:38; UTC

Įsigijimai, susijungimai, perėmimai

Paramount Makes $77.9 Billion Hostile Bid for Warner After Netflix Struck Deal -- 7th Update

2025-12-08 21:36; UTC

Rinkos pokalbiai

Oil Oversupply to Show Up As Waterborne Stocks Land -- Market Talk

2025-12-08 21:20; UTC

Įsigijimai, susijungimai, perėmimai

Will the Netflix-Warner Bros. Merger Go Through? It Depends on How You Define Market Share. -- Barrons.com

2025-12-08 21:12; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Moved the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

2025-12-08 21:08; UTC

Rinkos pokalbiai

Rosenberg Turns 'Outright Bullish' on Canada Dollar -- Market Talk

2025-12-08 20:38; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Co-CEOs Confident About Regulatory Approval for WBD Deal -- Market Talk

2025-12-08 20:26; UTC

Įsigijimai, susijungimai, perėmimai

These Stocks Are Moving the Most Today: Warner Bros., Paramount, Netflix, Tesla, CoreWeave, Confluent, Marvell, Carvana, and More -- Barrons.com

2025-12-08 20:18; UTC

Rinkos pokalbiai

Įsigijimai, susijungimai, perėmimai

Netflix Isn't Looking to Make Cuts at Warner Bros. Discovery -- Market Talk

2025-12-08 20:07; UTC

Rinkos pokalbiai

Oil Futures Snap Three-Session Winning Streak -- Market Talk

2025-12-08 20:06; UTC

Rinkos pokalbiai

U.S. Natural Gas Pulls Back From Weather-Driven Highs -- Market Talk

2025-12-08 20:05; UTC

Rinkos pokalbiai

Global Equities Roundup: Market Talk

2025-12-08 20:05; UTC

Rinkos pokalbiai

Deere Offers Sales Growth Forecast Through 2030 -- Market Talk

2025-12-08 20:01; UTC

Rinkos pokalbiai

Precious Metals Slip Ahead of Fed Decision -- Market Talk

Akcijų palyginimas

Kainos pokytis

Harmony Biosciences Holdings Inc Prognozė

Kainos tikslas

By TipRanks

15.49% į viršų

12 mėnesių prognozė

Vidutinis 46 USD 15.49%

Aukščiausias 62 USD

Žemiausias 32 USD

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Harmony Biosciences Holdings Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

10 ratings

Pirkti

Laikyti

Parduoti

Remiantis 10 analitikų, pateikusių Harmony Biosciences Holdings Inc akcijų reitingus – Dist per pastaruosius 3 mėnesius.

Techninis įvertinimas

By Trading Central

29.8 / N/APalaikymas ir pasipriešinimas

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

All events are bearish.

Rinkos nuotaikos

By Acuity

166 / 374 reitingas Sveikatos priežiūra

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

Apie bendrovę Harmony Biosciences Holdings Inc

Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients with rare and other neurological diseases in the United States. The company offers WAKIX (pitolisant), a molecule with a novel mechanism of action for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. It also offers HBS-102, a melanin-concentrating hormone receptor 1 for MCH neurons. The company was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. Harmony Biosciences Holdings, Inc. was incorporated in 2017 and is headquartered in Plymouth Meeting, Pennsylvania.